Wall Street ends higher with Apple shares as investors assess tariff exemptions

Uncertainty over future tariffs kept a lid on optimism, with the main indexes finishing off their highs of the day. Investors remain worried about how companies will manage supply chains as more changes are expected on the tariff front.
Global technology shares mostly rose on the news, especially for companies that rely on imports from
At the same time, an index of semiconductors rose just 0.3% and shares of top chipmaker Nvidia were down 0.2% on the day.
Monday's trading was choppy, as has been the case since Trump announced sweeping tariffs on
"Really what we have is just continued uncertainty and inability for consumers and businesses and investors to plan much going forward or have reason to commit to long-term spending plans," said Jed Ellerbroek, a portfolio manager at
The Dow Jones Industrial Average rose 312.08 points, or 0.78%, to 40,524.79, the S&P 500 rose 42.61 points, or 0.79%, to 5,405.97 and the Nasdaq Composite rose 107.03 points, or 0.64%, to 16,831.48.
The CBOE Volatility Index,
Technical analysts noted, though, that the S&P 500 is now in a "death cross" pattern, which marks a spot where a shorter-term correction could turn into a longer-term downtrend.
A death cross occurs when the 50-day moving average slips below the 200-day moving average.
History suggests the ominous-sounding signal may not necessarily mean equities face more significant downside. The S&P 500 remains down about 8% for the year so far.
Markets will be closed on
U.S. companies have begun to report results for the 2025 first quarter and, with tariff troubles looming, corporate executives may hold back on giving much guidance.
"Everybody knows the future is going to look a fair amount different than the past, and management teams are going to be really hesitant to commit to much," Ellerbroek said.
Still, shares of Goldman Sachs rose 1.9% on Monday after the bank reported higher first-quarter profit. Quarterly results from companies including Netflix and UnitedHealth Group are also on the radar this week.
Also gaining were some drugmakers after Pfizer said it would end the development of its experimental weight-loss pill. Pfizer shares ended 1% higher.
On the Nasdaq, 3,266 stocks rose and 1,200 fell as advancing issues outnumbered decliners by about a 2.72-to-1 ratio. There were 43 new highs and 101 new lows.
On the
Volume on U.S. exchanges was 18.2 billion shares, compared with the roughly 18.7 billion average for the full session over the last 20 trading days.
(Reporting by
(c) Reuters 2025. All rights reserved. Republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

Related News

-
World breathes sigh of relief as Trump spares Fed, IMF
Reuters - 6:06 AM ET 4/26/2025
-
Big tech earnings, US jobs data highlight busy week for markets
Reuters - 3:14 PM ET 4/25/2025
-
Exclusive-US pharma tariffs would raise US drug costs by $51 billion annually, report finds
Reuters - 12:36 PM ET 4/25/2025
-
Pirelli set to declare end of Chinese investor's control over governance, paper says
Reuters - 8:08 AM ET 4/26/2025
-
China's Xi calls for self sufficiency in AI development amid U.S. rivalry
Reuters - 12:25 AM ET 4/26/2025
-
DeepMind UK staff plan to unionise and challenge deals with Israel links, FT reports
Reuters - 9:01 AM ET 4/26/2025
-
ECB consensus builds for June rate cut but no appetite for big move, sources say
Reuters - 12:19 PM ET 4/26/2025